Logo image of NWH-DB-I.CA

NORTHWEST HEALTHCARE PRO (NWH-DB-I.CA) Stock Fundamental Analysis

TSX:NWH-DB-I - Toronto Stock Exchange - CA667495AK14 - Currency: CAD

100.45  -0.05 (-0.05%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NWH-DB-I. NWH-DB-I was compared to 43 industry peers in the Diversified REITs industry. While NWH-DB-I is still in line with the averages on profitability rating, there are concerns on its financial health. NWH-DB-I is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

NWH-DB-I had negative earnings in the past year.
NWH-DB-I had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: NWH-DB-I reported negative net income in multiple years.
NWH-DB-I had a positive operating cash flow in each of the past 5 years.
NWH-DB-I.CA Yearly Net Income VS EBIT VS OCF VS FCFNWH-DB-I.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of -7.77%, NWH-DB-I is doing worse than 74.42% of the companies in the same industry.
NWH-DB-I has a Return On Equity of -29.96%. This is in the lower half of the industry: NWH-DB-I underperforms 74.42% of its industry peers.
NWH-DB-I has a worse Return On Invested Capital (4.03%) than 69.77% of its industry peers.
NWH-DB-I had an Average Return On Invested Capital over the past 3 years of 2.72%. This is below the industry average of 5.49%.
The 3 year average ROIC (2.72%) for NWH-DB-I is below the current ROIC(4.03%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -7.77%
ROE -29.96%
ROIC 4.03%
ROA(3y)0.78%
ROA(5y)1.54%
ROE(3y)1.12%
ROE(5y)4.48%
ROIC(3y)2.72%
ROIC(5y)2.85%
NWH-DB-I.CA Yearly ROA, ROE, ROICNWH-DB-I.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

1.3 Margins

NWH-DB-I has a better Operating Margin (63.56%) than 83.72% of its industry peers.
NWH-DB-I's Operating Margin has been stable in the last couple of years.
NWH-DB-I has a Gross Margin of 75.37%. This is in the better half of the industry: NWH-DB-I outperforms 79.07% of its industry peers.
NWH-DB-I's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 63.56%
PM (TTM) N/A
GM 75.37%
OM growth 3Y-1.89%
OM growth 5Y-1.39%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5Y0.2%
NWH-DB-I.CA Yearly Profit, Operating, Gross MarginsNWH-DB-I.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100

More info and screens

2

2. Health

2.1 Basic Checks

NWH-DB-I has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, NWH-DB-I has more shares outstanding
Compared to 5 years ago, NWH-DB-I has more shares outstanding
The debt/assets ratio for NWH-DB-I is higher compared to a year ago.
NWH-DB-I.CA Yearly Shares OutstandingNWH-DB-I.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
NWH-DB-I.CA Yearly Total Debt VS Total AssetsNWH-DB-I.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 3.28 indicates that NWH-DB-I is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.28, NWH-DB-I belongs to the top of the industry, outperforming 93.02% of the companies in the same industry.
NWH-DB-I has a debt to FCF ratio of 35.83. This is a negative value and a sign of low solvency as NWH-DB-I would need 35.83 years to pay back of all of its debts.
The Debt to FCF ratio of NWH-DB-I (35.83) is worse than 86.05% of its industry peers.
NWH-DB-I has a Debt/Equity ratio of 1.75. This is a high value indicating a heavy dependency on external financing.
NWH-DB-I has a worse Debt to Equity ratio (1.75) than 88.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.75
Debt/FCF 35.83
Altman-Z 3.28
ROIC/WACC0.55
WACC7.36%
NWH-DB-I.CA Yearly LT Debt VS Equity VS FCFNWH-DB-I.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.3 Liquidity

NWH-DB-I has a Current Ratio of 0.27. This is a bad value and indicates that NWH-DB-I is not financially healthy enough and could expect problems in meeting its short term obligations.
NWH-DB-I's Current ratio of 0.27 is in line compared to the rest of the industry. NWH-DB-I outperforms 55.81% of its industry peers.
A Quick Ratio of 0.27 indicates that NWH-DB-I may have some problems paying its short term obligations.
NWH-DB-I has a Quick ratio (0.27) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.27
Quick Ratio 0.27
NWH-DB-I.CA Yearly Current Assets VS Current LiabilitesNWH-DB-I.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

More info and screens

2

3. Growth

3.1 Past

The earnings per share for NWH-DB-I have decreased strongly by -57.42% in the last year.
Looking at the last year, NWH-DB-I shows a very strong growth in Revenue. The Revenue has grown by 22.83%.
NWH-DB-I shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.76% yearly.
EPS 1Y (TTM)-57.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-69.49%
Revenue 1Y (TTM)22.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.76%
Sales Q2Q%-12.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y6.98%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.1%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NWH-DB-I.CA Yearly Revenue VS EstimatesNWH-DB-I.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
NWH-DB-I.CA Yearly EPS VS EstimatesNWH-DB-I.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.5 1 1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

NWH-DB-I reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 108.10, the valuation of NWH-DB-I can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NWH-DB-I is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of NWH-DB-I to the average of the S&P500 Index (22.65), we can say NWH-DB-I is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 108.1
NWH-DB-I.CA Price Earnings VS Forward Price EarningsNWH-DB-I.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as NWH-DB-I.
Based on the Price/Free Cash Flow ratio, NWH-DB-I is valued more expensive than 93.02% of the companies in the same industry.
Industry RankSector Rank
P/FCF 287.88
EV/EBITDA 70.56
NWH-DB-I.CA Per share dataNWH-DB-I.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

NWH-DB-I has a Yearly Dividend Yield of 10.04%, which is a nice return.
NWH-DB-I's Dividend Yield is rather good when compared to the industry average which is at 8.03. NWH-DB-I pays more dividend than 95.35% of the companies in the same industry.
NWH-DB-I's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 10.04%

5.2 History

The dividend of NWH-DB-I decreases each year by -3.23%.
NWH-DB-I does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)-3.23%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of NWH-DB-I are negative and hence is the payout ratio. NWH-DB-I will probably not be able to sustain this dividend level.
DP-16.42%
EPS Next 2YN/A
EPS Next 3YN/A
NWH-DB-I.CA Yearly Income VS Free CF VS DividendNWH-DB-I.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M

More info and screens

NORTHWEST HEALTHCARE PRO

TSX:NWH-DB-I (2/21/2025, 7:00:00 PM)

100.45

-0.05 (-0.05%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-14 2024-11-14
Earnings (Next)03-05 2025-03-05/amc
Inst Owners22.5%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap24.89B
Analysts70
Price Target119.71 (19.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 10.04%
Yearly Dividend0.61
Dividend Growth(5Y)-3.23%
DP-16.42%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.95%
PT rev (3m)11.52%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 108.1
P/S 40.32
P/FCF 287.88
P/OCF 284.97
P/B 15.14
P/tB 16.02
EV/EBITDA 70.56
EPS(TTM)-2
EYN/A
EPS(NY)0.93
Fwd EY0.93%
FCF(TTM)0.35
FCFY0.35%
OCF(TTM)0.35
OCFY0.35%
SpS2.49
BVpS6.64
TBVpS6.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.77%
ROE -29.96%
ROCE 6.57%
ROIC 4.03%
ROICexc 4.07%
ROICexgc 4.15%
OM 63.56%
PM (TTM) N/A
GM 75.37%
FCFM 14.01%
ROA(3y)0.78%
ROA(5y)1.54%
ROE(3y)1.12%
ROE(5y)4.48%
ROIC(3y)2.72%
ROIC(5y)2.85%
ROICexc(3y)2.77%
ROICexc(5y)2.96%
ROICexgc(3y)2.82%
ROICexgc(5y)3.03%
ROCE(3y)4.43%
ROCE(5y)4.64%
ROICexcg growth 3Y-5.44%
ROICexcg growth 5Y-2.28%
ROICexc growth 3Y-5.29%
ROICexc growth 5Y-1.28%
OM growth 3Y-1.89%
OM growth 5Y-1.39%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5Y0.2%
F-Score5
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 1.75
Debt/FCF 35.83
Debt/EBITDA 7.28
Cap/Depr 25.64%
Cap/Sales 0.14%
Interest Coverage 1.88
Cash Conversion 22.07%
Profit Quality N/A
Current Ratio 0.27
Quick Ratio 0.27
Altman-Z 3.28
F-Score5
WACC7.36%
ROIC/WACC0.55
Cap/Depr(3y)28.77%
Cap/Depr(5y)23.76%
Cap/Sales(3y)0.1%
Cap/Sales(5y)0.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-69.49%
EPS Next Y6.98%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.76%
Sales Q2Q%-12.43%
Revenue Next Year3.1%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.15%
EBIT growth 3Y8.67%
EBIT growth 5Y6.26%
EBIT Next Year10.78%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-56.25%
FCF growth 3Y-17.82%
FCF growth 5Y2.41%
OCF growth 1Y-55.96%
OCF growth 3Y-17.83%
OCF growth 5Y2.35%